D
8.42
-0.17 (-1.98%)
| Previous Close | 8.59 |
| Volume | 7,999 |
| Price / Sales | 5.38 |
| Price / Book | 1.00 |
| 52 Weeks Range |
| Profit Margin | 448.01% |
| Operating Margin (TTM) | -2,368.66% |
| Diluted EPS (TTM) | -0.090 |
| Quarterly Revenue Growth (YOY) | -41.80% |
| Quarterly Earnings Growth (YOY) | -34.70% |
| Total Debt/Equity (MRQ) | 2.04% |
| Current Ratio (MRQ) | 0.170 |
| Operating Cash Flow (TTM) | -1.68 M |
| Return on Assets (TTM) | -2.51% |
| Return on Equity (TTM) | 1.54% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Daxor Corporation | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 2.9 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Relative Valuation | NA |
| Financial Health | -5.0 |
| Macro Environment | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -0.16 |
Select this tab to load the latest available analysis.
|
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 56.90% |
| % Held by Institutions | 1.96% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Aristides Capital Llc | 30 Jun 2026 | 41,689 |
| Bfc Planning, Inc. | 30 Jun 2026 | 36,700 |
| Nano Cap New Millennium Growth Fund L P | 30 Jun 2026 | 12,500 |
| Crescent Grove Advisors, Llc | 30 Sep 2026 | 12,423 |
No data within this time range.
No data within this time range.
| 5Y Average Dividend Yield | 0.00% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 05 Jan 2018 | 28 Dec 2017 | 12 Jan 2018 | 0.03 Cash |
| 20 Dec 2016 | 18 Nov 2016 | 29 Dec 2016 | 0.03 Cash |
| 18 Dec 2015 | 09 Dec 2015 | 29 Dec 2015 | 0.04 Cash |
| 04 Dec 2014 | 17 Nov 2014 | 26 Dec 2014 | 0.03 Cash |
| 05 Dec 2013 | 15 Nov 2013 | 27 Dec 2013 | 0.05 Cash |
| 07 Dec 2012 | 29 Nov 2012 | 27 Dec 2012 | 0.1 Cash |
| 10 Aug 2012 | 03 Aug 2012 | 24 Aug 2012 | 0.1 Cash |
| 16 Nov 2011 | 08 Nov 2011 | 30 Nov 2011 | 0.1 Cash |
| 27 May 2011 | 25 May 2011 | 16 Jun 2011 | 0.15 Cash |
| 14 Dec 2010 | 30 Nov 2010 | 30 Dec 2010 | 0.65 Cash |
| 13 Sep 2010 | 02 Sep 2010 | 30 Sep 2010 | 0.25 Cash |
| 27 May 2010 | 11 May 2010 | 16 Jun 2010 | 0.1 Cash |
| 08 Dec 2009 | - | 24 Dec 2009 | 1 Cash |
| 21 Aug 2009 | - | 08 Sep 2009 | 0.25 Cash |
| 27 May 2009 | - | 15 Jun 2009 | 0.1 Cash |
| 10 Dec 2008 | - | 30 Dec 2008 | 1 Cash |
| 31 Oct 2008 | - | 26 Nov 2008 | 0.25 Cash |
| 24 Jul 2008 | - | 27 Aug 2008 | 0.25 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2018 | 0.030 | 1 | 0.37 |
| 2016 | 0.030 | 1 | 0.36 |
| 2015 | 0.040 | 1 | 0.53 |
| 2014 | 0.030 | 1 | 0.43 |
| 2013 | 0.050 | 1 | 0.73 |
| 2012 | 0.200 | 2 | 2.63 |
| 2011 | 0.250 | 2 | 2.75 |
| 2010 | 1.00 | 3 | 10.81 |
| 2009 | 1.35 | 3 | 11.20 |
| 2008 | 1.50 | 3 | 9.74 |
| Show more | |||
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |